Thomas Howard Howell, Jr., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Education, Dental | 21 | 2015 | 220 | 2.900 |
Why?
|
Students, Dental | 11 | 2015 | 170 | 1.110 |
Why?
|
Schools, Dental | 14 | 2015 | 121 | 1.000 |
Why?
|
Problem-Based Learning | 12 | 2015 | 360 | 0.940 |
Why?
|
Comprehensive Dental Care | 3 | 2015 | 16 | 0.910 |
Why?
|
Educational Measurement | 11 | 2015 | 1260 | 0.750 |
Why?
|
Periodontal Diseases | 13 | 2000 | 453 | 0.640 |
Why?
|
Periodontitis | 13 | 2003 | 576 | 0.590 |
Why?
|
Specialties, Dental | 3 | 2015 | 34 | 0.530 |
Why?
|
Dentistry, Operative | 5 | 2015 | 40 | 0.520 |
Why?
|
Gingivitis | 10 | 2007 | 126 | 0.510 |
Why?
|
Models, Educational | 4 | 2015 | 376 | 0.500 |
Why?
|
Teaching | 5 | 2015 | 1169 | 0.460 |
Why?
|
Dental Plaque | 6 | 2000 | 214 | 0.410 |
Why?
|
Licensure, Dental | 4 | 2015 | 17 | 0.410 |
Why?
|
Dental Health Services | 1 | 2011 | 48 | 0.370 |
Why?
|
Oral Medicine | 1 | 2011 | 36 | 0.370 |
Why?
|
Periodontics | 7 | 2013 | 45 | 0.360 |
Why?
|
Curriculum | 8 | 2015 | 3782 | 0.360 |
Why?
|
Mentors | 4 | 2011 | 671 | 0.350 |
Why?
|
Bone Morphogenetic Proteins | 5 | 2005 | 844 | 0.320 |
Why?
|
Alveolar Bone Loss | 11 | 2005 | 394 | 0.310 |
Why?
|
Patient-Centered Care | 2 | 2015 | 1458 | 0.280 |
Why?
|
Transforming Growth Factor beta | 5 | 2005 | 1995 | 0.270 |
Why?
|
Faculty, Dental | 5 | 2014 | 58 | 0.260 |
Why?
|
Prosthodontics | 4 | 2015 | 36 | 0.260 |
Why?
|
Periodontal Attachment Loss | 4 | 2001 | 151 | 0.240 |
Why?
|
Periodontal Pocket | 5 | 2007 | 174 | 0.230 |
Why?
|
School Admission Criteria | 3 | 2015 | 106 | 0.200 |
Why?
|
Platelet-Derived Growth Factor | 4 | 1997 | 615 | 0.180 |
Why?
|
Silver Sulfadiazine | 2 | 1990 | 9 | 0.180 |
Why?
|
Dogs | 16 | 2001 | 3822 | 0.180 |
Why?
|
Sulfadiazine | 2 | 1990 | 18 | 0.180 |
Why?
|
Boston | 10 | 2015 | 9338 | 0.180 |
Why?
|
Personal Satisfaction | 2 | 2015 | 641 | 0.180 |
Why?
|
Efficiency | 3 | 2013 | 480 | 0.170 |
Why?
|
Dentists | 2 | 2014 | 176 | 0.170 |
Why?
|
Alveolar Process | 9 | 2004 | 290 | 0.170 |
Why?
|
Gingival Hemorrhage | 6 | 2007 | 49 | 0.170 |
Why?
|
Educational Technology | 2 | 2015 | 61 | 0.170 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 5 | 2007 | 2268 | 0.170 |
Why?
|
Interleukin-11 | 1 | 2000 | 58 | 0.170 |
Why?
|
Endodontics | 4 | 2015 | 19 | 0.170 |
Why?
|
College Admission Test | 2 | 2012 | 11 | 0.160 |
Why?
|
Program Development | 3 | 2015 | 1295 | 0.160 |
Why?
|
Flurbiprofen | 8 | 1994 | 21 | 0.160 |
Why?
|
Periodontium | 3 | 2001 | 99 | 0.160 |
Why?
|
Gingival Crevicular Fluid | 5 | 2007 | 96 | 0.150 |
Why?
|
Denture, Partial, Removable | 2 | 2015 | 11 | 0.150 |
Why?
|
Denture, Complete | 2 | 2015 | 22 | 0.150 |
Why?
|
Furcation Defects | 1 | 1997 | 37 | 0.140 |
Why?
|
Bone Regeneration | 4 | 2005 | 436 | 0.140 |
Why?
|
Alveolar Ridge Augmentation | 3 | 2005 | 206 | 0.140 |
Why?
|
Dental Implantation, Endosseous | 1 | 2001 | 520 | 0.130 |
Why?
|
Specialty Boards | 2 | 2011 | 234 | 0.130 |
Why?
|
Bone Resorption | 8 | 1993 | 717 | 0.130 |
Why?
|
Dental Restoration, Permanent | 4 | 2009 | 130 | 0.130 |
Why?
|
Dental Implants | 3 | 2012 | 790 | 0.130 |
Why?
|
Mandible | 1 | 2001 | 746 | 0.130 |
Why?
|
Denture, Overlay | 1 | 2015 | 13 | 0.120 |
Why?
|
Preventive Dentistry | 1 | 2015 | 21 | 0.120 |
Why?
|
Prostaglandins | 2 | 1993 | 396 | 0.120 |
Why?
|
Problem Solving | 2 | 2015 | 440 | 0.120 |
Why?
|
Teaching Materials | 1 | 2015 | 85 | 0.120 |
Why?
|
Guided Tissue Regeneration, Periodontal | 1 | 1996 | 157 | 0.120 |
Why?
|
Online Systems | 1 | 2015 | 181 | 0.110 |
Why?
|
Periodontal Index | 6 | 1997 | 149 | 0.110 |
Why?
|
Academic Medical Centers | 1 | 2004 | 2780 | 0.110 |
Why?
|
Prostaglandin Antagonists | 2 | 1993 | 28 | 0.110 |
Why?
|
Dental Research | 2 | 2004 | 61 | 0.110 |
Why?
|
Insulin-Like Growth Factor I | 3 | 1997 | 1936 | 0.110 |
Why?
|
Nisin | 1 | 1993 | 4 | 0.110 |
Why?
|
Growth Substances | 1 | 1996 | 758 | 0.110 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5370 | 0.110 |
Why?
|
Anatomy | 1 | 2015 | 126 | 0.110 |
Why?
|
Dental Prosthesis, Implant-Supported | 1 | 2015 | 225 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2001 | 1387 | 0.100 |
Why?
|
Streptococcus | 3 | 1979 | 197 | 0.100 |
Why?
|
Training Support | 1 | 2013 | 109 | 0.100 |
Why?
|
Gels | 5 | 1997 | 419 | 0.100 |
Why?
|
Administration, Topical | 6 | 1997 | 704 | 0.100 |
Why?
|
Naproxen | 2 | 1992 | 99 | 0.100 |
Why?
|
Patient Care Team | 2 | 2015 | 2517 | 0.100 |
Why?
|
Dental Records | 1 | 2011 | 15 | 0.100 |
Why?
|
Computer-Assisted Instruction | 1 | 2015 | 368 | 0.100 |
Why?
|
Bone Morphogenetic Protein 2 | 4 | 2005 | 343 | 0.100 |
Why?
|
Interpersonal Relations | 4 | 2015 | 1432 | 0.090 |
Why?
|
Personnel Selection | 1 | 2014 | 201 | 0.090 |
Why?
|
Piroxicam | 1 | 1991 | 18 | 0.090 |
Why?
|
Feedback | 1 | 2015 | 796 | 0.090 |
Why?
|
Recombinant Proteins | 6 | 2005 | 6493 | 0.090 |
Why?
|
Forms and Records Control | 1 | 2011 | 158 | 0.090 |
Why?
|
Science | 2 | 2012 | 234 | 0.090 |
Why?
|
Program Evaluation | 2 | 2015 | 2499 | 0.090 |
Why?
|
Antimetabolites | 1 | 1991 | 127 | 0.090 |
Why?
|
Education, Predental | 1 | 2010 | 2 | 0.090 |
Why?
|
Dental Assistants | 1 | 2010 | 10 | 0.090 |
Why?
|
Clinical Competence | 4 | 2012 | 4863 | 0.090 |
Why?
|
Aptitude Tests | 1 | 2010 | 20 | 0.090 |
Why?
|
Collagen | 2 | 2005 | 2618 | 0.090 |
Why?
|
Career Choice | 3 | 2014 | 769 | 0.090 |
Why?
|
Dental Plaque Index | 4 | 2007 | 96 | 0.080 |
Why?
|
Education, Dental, Graduate | 2 | 2014 | 48 | 0.080 |
Why?
|
Group Processes | 1 | 2011 | 224 | 0.080 |
Why?
|
Pharmaceutical Vehicles | 2 | 2001 | 56 | 0.080 |
Why?
|
Minority Groups | 2 | 2014 | 1207 | 0.080 |
Why?
|
Peer Group | 1 | 2015 | 701 | 0.080 |
Why?
|
Self Concept | 1 | 2015 | 1037 | 0.080 |
Why?
|
Anti-Infective Agents, Local | 1 | 1991 | 245 | 0.080 |
Why?
|
Chi-Square Distribution | 4 | 2001 | 3432 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1509 | 0.070 |
Why?
|
Continuity of Patient Care | 1 | 2015 | 1078 | 0.070 |
Why?
|
Humans | 49 | 2015 | 765968 | 0.070 |
Why?
|
Analysis of Variance | 7 | 2005 | 6203 | 0.070 |
Why?
|
Placebos | 5 | 2007 | 1659 | 0.070 |
Why?
|
Random Allocation | 3 | 2001 | 2395 | 0.070 |
Why?
|
Dental Care | 2 | 2014 | 286 | 0.070 |
Why?
|
Coronary Disease | 1 | 2001 | 5912 | 0.070 |
Why?
|
Patient Care Planning | 1 | 2011 | 906 | 0.060 |
Why?
|
Dental Amalgam | 2 | 2009 | 64 | 0.060 |
Why?
|
Forecasting | 3 | 2010 | 2936 | 0.060 |
Why?
|
Learning | 1 | 2015 | 1755 | 0.060 |
Why?
|
Inflammation Mediators | 2 | 2007 | 1884 | 0.060 |
Why?
|
Oral Surgical Procedures, Preprosthetic | 1 | 2005 | 26 | 0.060 |
Why?
|
Motivation | 1 | 2015 | 2018 | 0.060 |
Why?
|
Dental Scaling | 4 | 2012 | 109 | 0.060 |
Why?
|
Statistics as Topic | 3 | 2002 | 2352 | 0.060 |
Why?
|
Parent-Child Relations | 1 | 2010 | 774 | 0.060 |
Why?
|
Indomethacin | 3 | 1993 | 322 | 0.060 |
Why?
|
Single-Blind Method | 3 | 2001 | 1589 | 0.060 |
Why?
|
San Francisco | 1 | 2004 | 166 | 0.060 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 3925 | 0.060 |
Why?
|
Tooth Socket | 1 | 2005 | 126 | 0.060 |
Why?
|
Root Planing | 3 | 2012 | 76 | 0.060 |
Why?
|
Communication | 2 | 2015 | 3916 | 0.050 |
Why?
|
Financial Support | 1 | 2004 | 116 | 0.050 |
Why?
|
Follow-Up Studies | 7 | 2015 | 39193 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2015 | 81514 | 0.050 |
Why?
|
Information Management | 1 | 2003 | 100 | 0.050 |
Why?
|
Propionates | 3 | 1988 | 180 | 0.050 |
Why?
|
Physicians | 1 | 2001 | 4588 | 0.050 |
Why?
|
Antigens, Bacterial | 2 | 1979 | 1146 | 0.050 |
Why?
|
Aspirin | 2 | 2007 | 3134 | 0.050 |
Why?
|
Observer Variation | 2 | 2000 | 2615 | 0.050 |
Why?
|
Somatomedins | 2 | 1996 | 177 | 0.050 |
Why?
|
Regeneration | 4 | 1997 | 1517 | 0.050 |
Why?
|
Staff Development | 1 | 2004 | 230 | 0.050 |
Why?
|
Organizational Objectives | 1 | 2004 | 426 | 0.050 |
Why?
|
Information Services | 1 | 2003 | 240 | 0.050 |
Why?
|
Molar | 2 | 2000 | 150 | 0.050 |
Why?
|
Leadership | 1 | 2011 | 1392 | 0.050 |
Why?
|
Maxilla | 1 | 2004 | 485 | 0.050 |
Why?
|
Cohort Studies | 4 | 2015 | 41649 | 0.050 |
Why?
|
Methylcellulose | 1 | 2001 | 34 | 0.050 |
Why?
|
Metalloendopeptidases | 1 | 2003 | 386 | 0.050 |
Why?
|
Organizational Innovation | 1 | 2004 | 541 | 0.050 |
Why?
|
Ibuprofen | 3 | 1993 | 228 | 0.050 |
Why?
|
Models, Organizational | 1 | 2004 | 547 | 0.040 |
Why?
|
Tooth Extraction | 2 | 2005 | 225 | 0.040 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2003 | 462 | 0.040 |
Why?
|
Radiography | 6 | 2000 | 6919 | 0.040 |
Why?
|
Bicuspid | 1 | 2000 | 69 | 0.040 |
Why?
|
Animals | 23 | 2003 | 168764 | 0.040 |
Why?
|
Disease Progression | 5 | 2001 | 13632 | 0.040 |
Why?
|
beta Carotene | 1 | 2001 | 522 | 0.040 |
Why?
|
Osseointegration | 1 | 2001 | 269 | 0.040 |
Why?
|
Dental Clinics | 2 | 2013 | 32 | 0.040 |
Why?
|
Aspartate Aminotransferases | 1 | 2001 | 415 | 0.040 |
Why?
|
Tongue | 2 | 1979 | 405 | 0.040 |
Why?
|
Linear Models | 5 | 2011 | 5876 | 0.040 |
Why?
|
Health Services Accessibility | 2 | 2014 | 5508 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2000 | 682 | 0.040 |
Why?
|
Double-Blind Method | 4 | 2005 | 12437 | 0.040 |
Why?
|
Thinking | 2 | 2012 | 322 | 0.040 |
Why?
|
Tooth Cervix | 1 | 1997 | 18 | 0.040 |
Why?
|
Models, Animal | 2 | 2003 | 2120 | 0.040 |
Why?
|
Radiography, Bitewing | 1 | 1997 | 36 | 0.040 |
Why?
|
Dental Prophylaxis | 2 | 2012 | 26 | 0.040 |
Why?
|
Ketoprofen | 1 | 1997 | 8 | 0.040 |
Why?
|
Schools, Medical | 1 | 2004 | 876 | 0.040 |
Why?
|
Drug Carriers | 2 | 2005 | 700 | 0.040 |
Why?
|
Periodontal Ligament | 2 | 1996 | 117 | 0.040 |
Why?
|
Pilot Projects | 4 | 2012 | 8733 | 0.030 |
Why?
|
Absorption | 1 | 1997 | 242 | 0.030 |
Why?
|
Dinoprostone | 2 | 2007 | 591 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 1997 | 254 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2011 | 4300 | 0.030 |
Why?
|
Drug Implants | 1 | 1997 | 230 | 0.030 |
Why?
|
Calibration | 1 | 1998 | 814 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 1600 | 0.030 |
Why?
|
Pediatric Dentistry | 1 | 2015 | 25 | 0.030 |
Why?
|
General Practice, Dental | 1 | 2015 | 32 | 0.030 |
Why?
|
Automation | 1 | 1997 | 585 | 0.030 |
Why?
|
Attitude | 2 | 2013 | 770 | 0.030 |
Why?
|
Primary Health Care | 1 | 2011 | 4736 | 0.030 |
Why?
|
Orthodontics | 1 | 2015 | 77 | 0.030 |
Why?
|
Female | 24 | 2012 | 396112 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2011 | 4873 | 0.030 |
Why?
|
Osteogenesis | 1 | 2001 | 1282 | 0.030 |
Why?
|
Massachusetts | 3 | 2014 | 8875 | 0.030 |
Why?
|
Software | 2 | 2004 | 4462 | 0.030 |
Why?
|
Clinical Enzyme Tests | 1 | 1993 | 114 | 0.030 |
Why?
|
Radionuclide Imaging | 2 | 1997 | 1978 | 0.030 |
Why?
|
Fluorides | 1 | 1973 | 134 | 0.030 |
Why?
|
Mouthwashes | 1 | 1993 | 57 | 0.030 |
Why?
|
Safety | 1 | 1997 | 1157 | 0.030 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 1992 | 361 | 0.030 |
Why?
|
Down-Regulation | 1 | 2000 | 2927 | 0.030 |
Why?
|
Osteoblasts | 2 | 1996 | 1143 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 2844 | 0.030 |
Why?
|
Denture, Partial, Fixed | 1 | 2012 | 42 | 0.020 |
Why?
|
Thromboxane B2 | 1 | 1992 | 143 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 1991 | 7478 | 0.020 |
Why?
|
Administrative Personnel | 1 | 2013 | 186 | 0.020 |
Why?
|
Root Canal Therapy | 1 | 2012 | 64 | 0.020 |
Why?
|
Longitudinal Studies | 5 | 1998 | 14751 | 0.020 |
Why?
|
Maxillary Diseases | 1 | 1991 | 46 | 0.020 |
Why?
|
Chlorhexidine | 1 | 1993 | 159 | 0.020 |
Why?
|
Wound Healing | 2 | 2001 | 2792 | 0.020 |
Why?
|
Crowns | 1 | 2012 | 156 | 0.020 |
Why?
|
Gingival Pocket | 1 | 1990 | 7 | 0.020 |
Why?
|
Surgical Flaps | 2 | 1997 | 1677 | 0.020 |
Why?
|
Mandibular Diseases | 1 | 1991 | 117 | 0.020 |
Why?
|
Tetracyclines | 1 | 1991 | 64 | 0.020 |
Why?
|
Adult | 11 | 2012 | 223044 | 0.020 |
Why?
|
Medically Underserved Area | 1 | 2013 | 266 | 0.020 |
Why?
|
Achievement | 1 | 2012 | 287 | 0.020 |
Why?
|
Subtraction Technique | 1 | 1993 | 512 | 0.020 |
Why?
|
Cause of Death | 1 | 2001 | 3708 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 1996 | 871 | 0.020 |
Why?
|
Epithelial Attachment | 1 | 1989 | 46 | 0.020 |
Why?
|
Dental Cementum | 1 | 1989 | 53 | 0.020 |
Why?
|
Dental Caries | 1 | 1973 | 429 | 0.020 |
Why?
|
Equipment Design | 1 | 1997 | 3481 | 0.020 |
Why?
|
Ligation | 2 | 2003 | 444 | 0.020 |
Why?
|
Antibodies | 1 | 1997 | 2417 | 0.020 |
Why?
|
Metronidazole | 1 | 1991 | 236 | 0.020 |
Why?
|
Infection Control, Dental | 1 | 2009 | 8 | 0.020 |
Why?
|
Clinical Clerkship | 1 | 1995 | 568 | 0.020 |
Why?
|
Dentist-Patient Relations | 1 | 2009 | 30 | 0.020 |
Why?
|
Time Management | 1 | 2009 | 53 | 0.020 |
Why?
|
United States | 6 | 2015 | 72903 | 0.020 |
Why?
|
Composite Resins | 1 | 2009 | 71 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2012 | 993 | 0.020 |
Why?
|
Dental Materials | 1 | 2009 | 113 | 0.020 |
Why?
|
Regression Analysis | 1 | 1997 | 6322 | 0.020 |
Why?
|
Reading | 1 | 2012 | 539 | 0.020 |
Why?
|
Prospective Studies | 3 | 2011 | 54802 | 0.020 |
Why?
|
Male | 13 | 2012 | 363698 | 0.020 |
Why?
|
Penicillins | 1 | 1991 | 404 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2013 | 1668 | 0.020 |
Why?
|
Arachidonic Acids | 1 | 1988 | 293 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2015 | 2739 | 0.020 |
Why?
|
Internet | 2 | 2014 | 3106 | 0.020 |
Why?
|
Time Factors | 5 | 2014 | 40065 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2001 | 14652 | 0.020 |
Why?
|
Leukotriene B4 | 1 | 2007 | 281 | 0.020 |
Why?
|
Middle Aged | 8 | 2005 | 223009 | 0.020 |
Why?
|
Feasibility Studies | 1 | 1997 | 5302 | 0.020 |
Why?
|
Stents | 1 | 1997 | 3213 | 0.020 |
Why?
|
Fibroblasts | 1 | 1996 | 4159 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2004 | 20124 | 0.010 |
Why?
|
Lipoxins | 1 | 2007 | 419 | 0.010 |
Why?
|
Technetium Tc 99m Medronate | 2 | 1997 | 134 | 0.010 |
Why?
|
Periapical Tissue | 2 | 1997 | 10 | 0.010 |
Why?
|
Internship and Residency | 2 | 2015 | 5946 | 0.010 |
Why?
|
Incidence | 2 | 2002 | 21480 | 0.010 |
Why?
|
Burnout, Professional | 1 | 2013 | 711 | 0.010 |
Why?
|
Immunization | 2 | 1979 | 1219 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2011 | 12056 | 0.010 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2003 | 13 | 0.010 |
Why?
|
Genetic Variation | 1 | 1979 | 6610 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 26318 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2000 | 18293 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1998 | 12976 | 0.010 |
Why?
|
Enzyme Precursors | 1 | 2003 | 164 | 0.010 |
Why?
|
Absorbable Implants | 1 | 2005 | 333 | 0.010 |
Why?
|
Rats | 4 | 2003 | 23707 | 0.010 |
Why?
|
Cyclophosphamide | 2 | 1979 | 2228 | 0.010 |
Why?
|
Bone Density | 2 | 2005 | 3491 | 0.010 |
Why?
|
Interleukin-1beta | 1 | 2007 | 1028 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 1546 | 0.010 |
Why?
|
Proteins | 1 | 1996 | 5995 | 0.010 |
Why?
|
Public Sector | 1 | 2002 | 264 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1724 | 0.010 |
Why?
|
Tooth | 1 | 1981 | 210 | 0.010 |
Why?
|
Private Sector | 1 | 2002 | 396 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2003 | 1886 | 0.010 |
Why?
|
Aggressive Periodontitis | 1 | 1999 | 59 | 0.010 |
Why?
|
Germ-Free Life | 1 | 1979 | 187 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2001 | 955 | 0.010 |
Why?
|
Connective Tissue | 2 | 1991 | 425 | 0.010 |
Why?
|
Dentifrices | 1 | 1997 | 6 | 0.010 |
Why?
|
Streptococcus mutans | 1 | 1978 | 99 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2004 | 8923 | 0.010 |
Why?
|
Aged | 3 | 2001 | 171117 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2007 | 3222 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13266 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2003 | 3586 | 0.010 |
Why?
|
Capsules | 1 | 1997 | 193 | 0.010 |
Why?
|
Stereoisomerism | 1 | 1997 | 614 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2003 | 1727 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2001 | 2910 | 0.010 |
Why?
|
Mouth Mucosa | 1 | 1978 | 432 | 0.010 |
Why?
|
Administration, Oral | 2 | 1992 | 4015 | 0.010 |
Why?
|
Diet, Cariogenic | 1 | 1973 | 6 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1979 | 617 | 0.010 |
Why?
|
Risk Factors | 1 | 2001 | 74840 | 0.010 |
Why?
|
Inflammation | 1 | 1993 | 10850 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 1997 | 872 | 0.010 |
Why?
|
Prostaglandins F | 1 | 1992 | 79 | 0.010 |
Why?
|
Age of Onset | 1 | 1999 | 3344 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2003 | 8102 | 0.010 |
Why?
|
Epitopes | 1 | 1978 | 2523 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 1991 | 360 | 0.010 |
Why?
|
Subgingival Curettage | 1 | 1989 | 11 | 0.010 |
Why?
|
Osteocytes | 1 | 1991 | 193 | 0.010 |
Why?
|
Prosthesis-Related Infections | 1 | 1994 | 496 | 0.000 |
Why?
|
Odds Ratio | 1 | 2001 | 9649 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2003 | 12768 | 0.000 |
Why?
|
Tooth Root | 1 | 1988 | 161 | 0.000 |
Why?
|
Iodine Radioisotopes | 1 | 1991 | 1029 | 0.000 |
Why?
|
Radiopharmaceuticals | 1 | 1997 | 2699 | 0.000 |
Why?
|
Feces | 1 | 1973 | 1504 | 0.000 |
Why?
|
Arachidonic Acid | 1 | 1988 | 430 | 0.000 |
Why?
|
Prevalence | 1 | 2002 | 15842 | 0.000 |
Why?
|
Drug Combinations | 1 | 1991 | 2077 | 0.000 |
Why?
|
Delayed-Action Preparations | 1 | 1988 | 967 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2001 | 15398 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2004 | 20659 | 0.000 |
Why?
|
Jaw Diseases | 1 | 1981 | 91 | 0.000 |
Why?
|
Child, Preschool | 1 | 1999 | 42500 | 0.000 |
Why?
|
Child | 1 | 1999 | 80564 | 0.000 |
Why?
|
Adolescent | 1 | 1999 | 88835 | 0.000 |
Why?
|
Treatment Outcome | 1 | 1997 | 65188 | 0.000 |
Why?
|